Infliximab Is Not Associated With Increased Risk of Malignancy or Hemophagocytic Lymphohistiocytosis in Pediatric Patients With Inflammatory Bowel Disease

JS Hyams, MC Dubinsky, RN Baldassano, RB Colletti, S Cucchiara, Hankje Escher, W Faubion, J Fell, BD Gold, A Griffiths, S Koletzko, S Kugathasan, J Markowitz, FM Ruemmele, G Veereman, H Winter, N Masel, CR Shin, KZL Tang, M Thayu

Research output: Contribution to journalArticleAcademicpeer-review

176 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)1901-+
Issue number8
Publication statusPublished - 2017

Research programs

  • EMC MM-04-54-07

Cite this